Our network of collaborations and partnerships has been developed and fostered over the years. We have established strong connections with policy and practice decision-makers at local, national and international levels. MCTR has established itself as a global leader in Transfusion Medicine through its strong partnerships with:
Canadian Blood Services supported research is focused on utilization of blood products and plasma derivatives,
Over the years, MCTR has worked closely with the Ontario Ministry of Health and Long-Term Care (MOHLTC) and the Ontario Regional Blood Coordinating Network (ORBCoN) on key priority areas in Transfusion Medicine. MCTR faculty are members of the Ontario IVIG advisory panel and led the IVIG hematology indications revision (2016). Partnerships with governmental agencies have allowed MCTR to directly participate in policy and practice-change initiatives at the provincial level.
MCTR collaborates with two groups within Health Canada: the Public Health Agency of Canada (PHAC) and the MOHLTC to study transfusion-related adverse events through the development of Ontario’s Transmitted Injuries Surveillance System (TTISS). TTISS – Ontario is a real-time transfusion surveillance database that is being used by over 100 provincial hospitals. Educational and research projects are also integrated into the program to advance knowledge of transfusion reaction recognition, classification, and reporting.
Members of MCTR are actively involved in the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Members have served as co-chair, project leads, and international collaborators.
Members of MCTR have active leadership roles in a number of international societies: